|
|
|
Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders |
K. Tamura1, H. Takahashi1, *( ), S. Uchida1, M. Ogoyama1, R. Usui1, S. Matsubara1 |
1Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan |
|
|
Abstract Several studies indicate that intrauterine balloon (IUB) use is less effective for postpartum hemorrhage (PPH) due to placenta accreta spectrum (PAS) disorders than that due to atonic bleeding. IUB failed to achieve hemostasis because the present two cases had normally positioned PAS. Case Report: A 37-year-old woman was transferred due to PPH. She vaginally delivered. The placenta was without macroscopic defect. Atonic bleeding was suspected. An IUB was placed, without achieving hemostasis. Her status deteriorated, necessitating a hysterectomy. The placenta remained, adhering to the uterine body. Histological examination revealed placenta accreta. The second case was a 40-year-old woman that was transferred due to PPH of atonic bleeding after vaginal delivery. The placenta was without macroscopic defect. An IUB was placed, without hemostasis, and was subsequently was removed. Conservative treatment achieved hemostasis. An Ultrasound revealed the placenta in the uterine body. We diagnosed her with clinical PAS. Nonprevia PAS may be present when an IUB fails to achieve hemostasis.
|
Submitted: 22 April 2019
Accepted: 24 June 2019
Published: 15 June 2020
|
*Corresponding Author(s):
HIRONORI TAKAHASHI
E-mail: hironori@jichi.ac.jp
|
[1] |
Revert M., Cottenet J., Raynal P., Cibot E., Quantin C., Rozenberg P.: “Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study”. BJOG, 2017, 124, 1255.
doi: 10.1111/1471-0528.14382
pmid: 27781401
|
[2] |
Vintejoux E., Ulrich D., Mousty E., Masia F., Mares P., de Tayrac R., et al.: “Success factors for Bakri™ balloon usage secondary to uterine atony: a retrospective, multicentre study”. Aust. N. Z. J. Obstet. Gynaecol., 2015, 55, 572.
doi: 10.1111/ajo.12376
pmid: 26223852
|
[3] |
Ogoyama M., Takahashi H., Usui R., Baba Y., Suzuki H., Ohkuchi A., et al.: “Hemostatic effect of intrauterine balloon for postpartum hemorrhage with special reference to concomitant use of “holding the cervix” procedure (Matsubara)”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2017, 210, 281.
doi: 10.1016/j.ejogrb.2017.01.012
pmid: 28088108
|
[4] |
Kong C.W., To W.W.: “Prognostic factors for the use of intrauterine balloon tamponade in the management of severe postpartum hemorrhage”. Int. J. Gynaecol. Obstet., 2018, 142, 48.
doi: 10.1002/ijgo.12498
pmid: 29603742
|
[5] |
Georgiou C.: “Balloon tamponade in the management of postpartum haemorrhage: a review”. BJOG, 2009, 116, 748.
doi: 10.1111/j.1471-0528.2009.02113.x
pmid: 19432563
|
[6] |
Brown H., Okeyo S., Mabeya H., Wilkinson J., Schmitt J.: “The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage”. Int. J. Gynaecol. Obstet., 2016, 135, 276.
doi: 10.1016/j.ijgo.2016.06.021
pmid: 27612530
|
No Suggested Reading articles found! |
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|